Global Investment Trends and Getting Noticed by PE/VC Firms

Iesan Tsai, of Asia-based investment firm Kiri Capital, explains what life sciences companies can do to get noticed by investors and her outlook on market timelines, investing after a pandemic, and the top trending technologies.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: